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Abstract 
Neuromodulation by electrical stimulation of the human cervical vagus nerve may be limited 
by adverse side effects due to stimulation of off-target organs. It may be possible to overcome 
this by spatially selective stimulation of peripheral nerves. Preliminary studies have shown this 
is possible using a cylindrical multielectrode nerve cuff optimised for human vagus nerve 
selective neuromodulation. The design was optimised initially by computer modelling. This 
suggested two rings of 14 electrodes, 3 mm apart, with 0.4 mm electrode width and separation 
and length 0.5-3 mm, with stimulation through a pair in the same radial position on the two 
rings. The electrodes were fabricated using PDMS-embedded stainless steel foil and PEDOT: 
pTS coating. In the cervical vagus nerve in anaesthetised sheep, it was possible to selectively 
reduce the respiratory rate (RR) by 85  5% without affecting heart rate, or selectively reduce 
heart rate (HR) by 20  7% without affecting respiratory rate. The cardiac- and pulmonary-
specific sites on the nerve cross-sectional perimeter were localised with a radial separation of 
105  5 degrees (P < 0.01, N = 24 in 12 sheep). This suggests there is organotopic organisation 
of neural fibres in the cervical vagus nerve. It demonstrates, for the first time, selective 
electrical neuromodulation without adverse side effects. It may be possible to translate this to 
improved treatment by electrical autonomic neuromodulation for currently intractable 
conditions. 
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1. Introduction 
In recent years, electrical neuromodulation of peripheral 
nerves to relieve various conditions has received a dramatic 
increase in interest in the academic and industrial community 
[1–3]. The concept is to place a small cuff device around a 
nerve to send electrical impulses, generating action potentials, 
which are transmitted to the organ of interest and hence 
modulate the function of the organ. Such devices are currently 
used in clinics for the management of drug-resistant epilepsy 
[4], chronic heart failure [5,6], stroke rehabilitation [7], 
chronic inflammation [8], and also other disease models [9] 
have promising results in animals. Due to the relative ease of 
surgical access, most of the current peripheral nerve 
interfacing devices are implanted in the neck to interface with 
the cervical vagus, the main autonomic trunk to all organs of 
  
the body [10]. However, there is ongoing investigation of their 
use in smaller peripheral nerves such as sacral [11] or tibial 
[12] nerves for overactive bladder, peroneal nerve for foot 
drop [13], hypoglossal nerve for obstructive sleep apnoea [14], 
or occipital nerve for chronic pain management [15]. 
Although there have been promising results in animal 
studies, few vagus nerve stimulation devices reach clinical 
approval. Current autonomic nerve interfaces stimulate the 
nerve bundle indiscriminately. As the vagus nerve innervates 
numerous organs, including the heart, lungs, intestines, 
spleen, and larynx, non-targeted neuromodulation of the nerve 
causes off-target effects, which limits the applicability of such 
devices. Human vagal nerve stimulators for epilepsy, for 
example, cause cough, voice alteration, nausea, and pain [16], 
which are evoked by activation of pulmonary afferents, 
recurrent laryngeal efferents, and pain nociception fibres. A 
study into the effectiveness of treatment for chronic heart 
failure concluded that effective treatment cannot be delivered 
without side effects such as dysphonia, cough and stimulation-
related pain. These necessitated reduction of the stimulation 
intensity which in turn reduced or eliminated the therapeutic 
effect [9]. 
A potential way of eliminating side effects would be to 
deliver the current in a spatially selective way, where only the 
specific part of the nerve containing the required nerve fibres 
is activated. This can be achieved through either current 
steering with an external cuff device [17–19] or penetrating 
electrode arrays [20,21]. The latter is currently far away from 
clinical applications because of concerns regarding their 
chronic use; the presence of rigid foreign material in nerves 
causes tissue damage and an inflammatory response [22,23]. 
The application of flexible extra-neural multi-electrode 
devices on vagus nerves to aid selectivity of recruitment is a 
viable option, but it is still at an early stage. The most recent 
advances demonstrated blood pressure control without side 
effects in rats [24], and selective neuromodulation of cardiac, 
pulmonary, urinary, and endocrine function in dogs [25]. 
There are also some preliminary results on selective alteration 
of heart function in humans [26]. However, those studies used 
arbitrary electrode geometries and count; electrode arrays 
were reportedly difficult to fabricate, and the latter studies 
were performed in two dogs and four humans, respectively, 
with inconsistent results on efficacy and inconsistent 
physiological alterations reported.  
Hence, there is a clear need for the investigation and 
optimisation of such extra-neural multi-electrode cuff arrays, 
which can be surgically implanted around peripheral nerves, 
such as the vagus nerve, and can potentially be used for 
multiple disease treatments by altering the spatial selectivity 
of the current to the fascicle of interest. 
In terms of the applied stimulation waveform, there is a 
multitude of pulse waves which can be employed to increase 
efficiency of the neuronal stimulation, ranging from 
unidirectional square to decaying or raising exponential [22], 
[23]. Most human-approved devices, however, use a biphasic 
charge balanced waveform due to the safety reasons [29] and 
the fact that an implantable pulse generator with such high 
resolution waveforms is highly energy inefficient and 
difficult.  
Total multi-parametric optimisation of the device is near-
impossible in this case due to the number of variables involved 
in the optimisation process. Several studies have demonstrated 
optimisation of a certain subset of parameters, while fixing 
other parameters for various reasons. Specifically, in [30] a 
method was developed which evaluated optimal multi-polar 
stimulation patterns and applied waveforms, while geometry 
of the device itself was fixed. The authors used generic 
human-sized vagus nerves, and demonstrated the 
effectiveness of optimisation in vivo and chronically. While 
these studies showed promising results, the geometrical 
optimisation of the multi-electrode cuff itself has never been 
performed before. 
The purpose of the presented work was to optimise the 
geometrical parameters of the array in a generic nerve model, 
while waveform and pulse duration was fixed, and test the 
efficiency of the optimised array in vivo in human-sized vagus 
nerves (sheep).  
Particular questions were: a) What is the optimal geometry, 
configuration, and number of electrodes in the cuff? b) Does 
the optimal device work in in vivo acute animal experiments? 
2. Methods 
2.1 Experimental Design 
As mentioned above, we employed a biphasic symmetric 
square pulse as this is a reliable standard used in implantable 
stimulators [29]. The optimisation of the array geometry was 
performed in simulations where a 3D FEM model of a human-
sized nerve was used to compute static current and voltage 
distributions. It was further coupled through an activating 
function to 1D time-dependent FEM models of the myelinated 
axons, running inside and parallel to the nerve, which was 
used to simulate action potential (AP) initiation and 
propagation at any given cross-sectional location [31]. During 
optimisation, we targeted specific axons inside the nerve in 
two locations and computed the threshold current required for 
those given axons to fire an action potential. We explored a 
wide range of geometric parameters and computed an 
objective function (OF) resampling combination of two 
unwanted ‘side effects’ of targeted stimulation: 1) total cross-
sectional area of the nerve where axons have been activated in 
addition to the target axon, and 2) threshold current density 
directly under the electrodes. The combined influence of both 
effects was computed as a normalised sum and minimised. 
First, we assumed symmetric configuration of one pair of 
electrodes along the nerve, and optimised their dimensions 
and the distance between them. Then we showed that an 
  
optimal symmetric configuration gave the best results among 
any (non-symmetric and symmetric) configuration, and, in 
particular, demonstrated its superiority against a multi-
electrode configuration. During the last stage of this process 
we calculated the optimum space between the symmetric pairs 
along the circumference of the nerve, and formulated the final 
specifications for the optimum cuff electrode array. 
The suggested optimal design was adjusted given real-life 
manufacturing and impedance considerations and then 12 
devices were manufactured and implanted around the cervical 
vagus nerve in 12 healthy anaesthetised sheep. Electrical 
stimulation was performed on each of the 14 electrode pairs in 
the array in turn; thus, activating 14 spatial sections around the 
nerve while measuring respiratory rate (RR) through end-tidal 
CO2 (EtCO2), and heart rate (HR) through electrocardiogram 
(ECG) and arterial blood pressure (ABP). Sites with 
significant changes in respiratory or cardiac rate were 
identified. The stimulation current amplitude was then 
adjusted if necessary with the aim of selective activation of 
HR without effect on the RR and vice versa. 
2.2 Model-based optimisation 
A 3D cylindrical model of a human-sized vagus nerve was 
produced in the COMSOL simulation software (COMSOL 
Ltd, UK). The model was made without fascicular 
organisation as the this varies from species to species and will 
be unknown a priori for a particular subject. Previous studies 
have also shown negligible effect of fasciculation and 
applicability of a generic model for accurate predictions in the 
experiments [30]. The model was 2.8 mm in diameter, and had 
two compartments: intraneural space (homogeneous 
conductivity of 0.3 S/m) and 100 μm-thick epineurium (0.083 
S/m, [32]) surrounding the latter (Figure 1). 
 Discretisation was performed according to mesh 
convergence criteria resulting in the optimal mesh to be 5M 
regular tetrahedral elements with refined area near the 
application of the electrodes. The electrodes were modelled 
using surface impedance, which accounts for non-
homogeneities of the current distribution due to contact 
impedance. The impedance of the electrodes was set to 500 
Ohm·mm2 to match experimentally evaluated impedances for 
actual electrode arrays [33]. The external boundary conditions 
were supplied as a constant normal current density on the 
electrodes. The problem was solved in quasi-static 
formulation (Figure 2, block 1). 
Two radially located “virtual fibres” were placed beneath 
the electrodes, one at a third and another at two thirds of the 
radius towards the nerve centre, to serve as a target for 
neuronal stimulation. The simulations were performed for 
each set of parameters 𝑝𝑖  (Table 1), supplying unit current 
between the electrodes and evaluating the voltage distribution 
in the volume 𝑉. Then the activating functions were computed 
along the virtual fibre locations [34]: 
𝑔(𝑥) =
𝜕2𝑉(𝑥)|𝑦=𝑦0,𝑧=𝑧0 
𝜕𝑥2
 (1) 
where 𝑥 was the longitudinal direction parallel to the axon, 
and (𝑦0, 𝑧0) were the cross-sectional coordinates of the fibre. 
The activating function was multiplied by a temporal 
biphasic square pulse (positive first) with 50 µs pulsewidth 
(Figure 2, block 2,3). The resulting spatiotemporal function 
was applied as a boundary condition to the time-dependant 
model of myelinated axon.  
An accurate 1D FEM double-cable model of a mammalian 
myelinated sensory fibre was used as a fibre model [35]. It 
contained ten ion channels taken from an experimentally 
validated space-clamped model [36]: four at the node and six 
at the internode. A realistic morphology of the fibre [37] was 
implemented similarly to the one used in [38]. The conduction 
velocity of the fibre and the shape of membrane potential at 
the nodes and internodes in resting state and during excitation, 
matched an experimentally validated space-clamped model 
[36]. The complete description and validation of the model is 
presented in [35]. 
 
Figure 1. a) A representative semi-thin histological 
section of a sheep vagus nerve, and b) the generic model of 
the human-sized vagus nerve used for optimisation process. 
  
The amplitude of the activating function was varied in order 
to find the threshold of activation. It was determined for each 
set of parameters using an iterative linear search.  
After the threshold 𝑔𝑎 of activation for the activating 
function was established, the threshold current needed for 
activating the fibre was recalculated for each parameter 𝑝𝑖 . 
Then the total activated area in the cross-section (above the 
activation threshold) 𝐴(‖𝑔(𝑥)‖ > 𝑔𝑎), and maximum current 
density directly beneath the electrodes 𝐽𝑖 were calculated. The 
normalised sum was computed as an objective cost function 
 
Figure 2. Experimental design and overview of the model-based optimisation methods for step 1 (symmetric longitudinal 
configuration). A generic homogeneous 3D model with two compartments (epineurium and intra-neural space) of the nerve was 
used to study the effects of electrode geometry and optimise geometric parameters according to the flowchart. The quasi-static 
fields were computed using this model (1), from which the representative shapes of the activating function were extracted (2) 
and applied as a boundary condition to the time-dependant model of the myelinated axon (3). Using the iterative linear search, 
the threshold of activation was detected, the threshold current was computed, and active areas were mapped back to the 3D 
model (4). After this, the OCF was computed for each geometrical configuration and studied. Minimal OCF indicated optimal 
geometrical parameters. Two exemplar parameter sets are presented for illustrative purposes.  
  
(OCF) and minimised over the parameters (note that the 
maximum active area equals to the half of cross-sectional area 
of the nerve 
1
2
𝜋𝑅2, where R = 1.4 is the nerve radius): 
𝐹𝑖 =
𝐽𝑖
max
𝑖
‖𝐽𝑖‖
+
𝐴(‖𝑔𝑖(𝑥)‖ > 𝑔𝑎
𝑖 )
1
2 𝜋𝑅
2
 (2) 
𝑝𝑜𝑝𝑡 =
argmin(𝐹𝑖)
𝑃𝑖
 (3) 
 
Optimisation was performed in three steps: 
Array optimisation step 1: Optimisation of symmetrically 
located pair of electrodes. 
Before considering more complex geometrical 
arrangements, a symmetrical longitudinal bipolar 
configuration was optimised. Here, a single pair of identical 
electrodes was placed longitudinally along the nerve on the 
same radial “o’clock” position. Electrode width, length, and 
distance between the electrodes were varied using the range of 
parameters in Table 1. Once all permutations of parameters 
were computed (total 10 000) the best combination according 
to the criteria (3) was selected.  
Array optimisation step 2: Proof that the symmetric 
configuration is the most optimal among all other geometric 
arrangements of two electrodes. 
Here, given the symmetry of the problem, one of the 
electrodes was fixed with its optimal parameters, while the 
other was changed: the width and length of the electrode, as 
well as its radial and longitudinal location were increased from 
half of the optimum value to double. The OCF (2) was 
computed along the change of each individual parameter. The 
OCF increased per each permutation indicating that the 
optimal parameters from step 1 satisfied criteria of at least 
local minima over more general space of geometric 
configurations. To illustrate this point further, the cost 
function was computed for several examples previously used 
in literature: 1) 2-electrode cross-sectional adjacent, where 
electrodes were located in the same longitudinal position but 
different “o’clock” locations, and 2) multi-electrode, where 
current from one electrode was “spread” over multiple (6) 
other electrodes either in a cross-sectional configuration or 
shifted along the nerve to the optimal longitudinal distance. 
Array optimisation step 3: Computation of radial spacing 
between the pairs in the array. 
Once the optimal parameters were computed and 
symmetric configuration was proven optimal, the spacing 
between the pairs, or their respective “o’clock” positions, was 
computed by half of the length of the maximum spread of the 
activated area 𝐴(‖𝑔𝑖(𝑥)‖ > 𝑔𝑎
𝑖 . In other words, for the given 
electrode pair, the neighbouring pairs were placed so that they 
were on the edge of the activation area. 
 
Figure 3. Schematic diagram of step 2 of the array 
optimisation. The optimisation of the symmetric 
longitudinal pair (Figure 2) was taken as a starting point 
(middle) and then each of the geometric parameters (length, 
width, radial location, and distance) was perturbed around 
this starting location for one electrode. The OCF was 
increasing in response to change in any parameter in any 
direction. Hence, the starting configuration satisfied at least 
local minimum. Three alternative common configurations 
were tested (see 2.2) with similar increase in OCF. 
 
Table 1. Ranges of electrode parameters used for 
optimisation 
Parameter Width (W) Length (L) Distance 
between 
electrodes (D) 
Range  0.05 – 2.0 
mm 
0.5 – 4.5 
mm 
0.5 – 4.5  
mm  
 
Selected optimal parameters were then slightly adjusted 
given the practicality of the manufacturing and in vivo 
experimental requirements (mainly laser cutting accuracy of 
0.03 mm, PDMS stiffness, and real-life contact impedance 
  
after PEDOT: pTS coating) and optimal designs were 
produced as described in the next section. 
2.3 Electrode array fabrication 
Optimal electrodes were fabricated using a laser cutting 
stainless steel-on-silicone rubber approach. Connecting tracks 
were 150 µm wide with an inter-track spacing of 35 µm. The 
total thickness of the array was 220 to 250 µm. After 
fabrication, electrodes were coated with PEDOT:pTS to 
reduce contact impedance below 1 kOhm at 1kHz for each 
electrode [33]. 
The following protocol was used (Figure 4): 1) A 10 μm 
release layer (Poly(4-Styrenesulfonic Acid), Sigma Aldrich, 
UK) was spin-coated on the 70x40 mm glass slides (Fisher 
Scientific, UK) followed by approximately 100 μm layer of 
the silicone rubber (MED4-4220, Polymer Systems 
Technology Ltd, US). 2) The silicone was cured for 5 mins at 
100C in the oven. 3) Stainless steel foil (0.0125 mm, Advent 
Research Materials, UK) was glued on top of the rubber. 4) 
The electrode profile was cut using a 20 W precision laser 
cutter (355 nm, IDG lab, UCL, UK). 5) Excess foil was peeled 
off, and the second 100 μm layer of the silicone rubber spin-
coated on top. 6) The electrode openings and connector pads 
were laser-cut and peeled away. 7) Finally, the array was glued 
on the inside of the 3 mm ID silicone rubber tube (Sigma-
Aldrich, UK) with thread mounted to assist implantation and 
the connector side was attached to a custom PCB using three 
20-way 1.5 mm connectors (Farnell, UK). The complete 
fabrication process, together with the evaluation of the 
electrode performance, can be found in [33]. 
2.4 In vivo experiments 
2.4.1. Anaesthesia and Maintenance. Twelve sheep were 
anaesthetised by induction using ketamine (5 mg/kg) and 
midazolam (0.5 mg/kg) injected IV into the jugular vein. A 
tracheal tube was then inserted into the trachea for the primary 
purpose of establishing and maintaining a patent airway and 
to maintain general anaesthesia using sevoflurane carried in 
an oxygen/air mixture. After induction of general anaesthesia, 
the animal was positioned in dorsal recumbency. Indwelling 
catheters were percutaneously placed in both the external 
jugular veins and one in the femoral artery (for blood pressure 
and blood gas monitoring) using ultrasonographic guidance. 
An intra-oesophageal tube was inserted to drain refluxes from 
the rumen. The animal was instrumented with ECG leads and 
a pulse oximeter. A spirometer was connected to the tracheal 
tube. An intranasal probe was used to control temperature. 
2.4.2. Surgery. The palpebral and corneal reflexes, 
medioventral eye ball position, and jaw tone were used to 
monitor anaesthetic depth prior to surgery initiation. 
Nystagmus as well as lacrimation were monitored as possible 
signs of a light plane of anaesthesia. The animal was 
mechanically ventilated using a pressure control mode for the 
duration of the surgery and implantation, after which the 
animal was kept on spontaneous ventilation during the 
stimulation sessions. Animals were placed onto mechanical 
ventilation between rounds of stimulations if required to 
restore normal levels of CO2 (between 35-45 mmHg). Body 
temperature was maintained using a hot air warming system if 
 
Figure 4. Electrode fabrication procedure. a) The 
stainless steel foil is attached to a PDMS substrate, laser-
cut, coated with second layer of PDMS and patterned 
following electrode sites opening. b) Electrode sites are 
coated with PEDOT:pTS. c) The cuff is formed into the 
tubular configuration by either using existing PDMS tube 
or glued to a sandwiched pre-stressed PDMS sheets. 
  
necessary. Ringer lactate fluid therapy at a rate of 5 ml/kg/h 
was administered intravenously throughout the procedure. 
Glucose was administered at the discretion of the anaesthetist 
when blood glucose was lower than 4 mmol/L. 
2.4.3. Monitoring and recordings. Arterial blood gases were 
analysed using a blood gas machine (i-stat, Abbott, USA) 
throughout the experiment to monitor pH, Glucose, PaO2, 
PaCO2, Bicarbonate, SaO2, Na+, Cl-, Ca2+ and K+ levels. All 
physiological parameters (including HR, systemic arterial 
blood pressure (sABP), central venous pressure) as well as the 
level of delivered sevoflurane were recorded. Depth of 
anaesthesia throughout the experiment was assessed by 
inspecting physiological parameters as well as using a 
bispectral index monitoring system (BisTM, Medtronic, 
USA). Levels of sevoflurane were adjusted accordingly by the 
anaesthetist. In some cases, boluses of propofol or fentanyl 
were used, if required, and noted on the records. Physiological 
data were outputted from the anaesthesia monitor (Aestiva 5, 
General Electric, Finland) into a 16-channel Powerlab system. 
Raw ECG, systemic arterial blood pressure (sABP), end-tidal 
CO2, % of expired Sevoflurane, and central venous pressure 
were digitalised by a Powerlab acquisition system and 
sampled at 2000 Hz with LabChart 8.0 software (AD 
Instruments, UK). Calculated channels (for live measurement 
of HR, systolic ABP, diastolic ABP, mean ABP, respiratory 
rate) were added in the Labchart as needed. A trigger channel 
was also used to link the stimulator to the physiological data.  
2.4.4. Electrode implantation. After induction of 
anaesthesia and placement in dorsal recumbency, the ventral 
neck region was clipped and aseptically prepared using 
chlorhexidine-based solutions, prior to the placement of sterile 
drapes, leaving only a small window open for accessing the 
right cervical vagus nerve. Using aseptic technique, a 20 cm 
longitudinal skin incision was made using monopolar 
electrocautery centred immediately to the right of the trachea 
from the larynx caudad. The incision was continued through 
the subcutaneous tissue and the sternohyoideus musculature 
using a sharp/blunt technique until encountering the carotid 
sheath and right vagus nerve. Two segments measuring 3-5 
cm each of the right vagus nerve (RVN) were 
circumferentially isolated by blunt dissection. Artery forceps 
were then inserted under the nerve from lateral to medial, 
grasping one pair of suture glued to the custom made cuff 
electrode array introduced into the surgical field. The cuff was 
placed around the nerve by pulling on the opposite pair of 
sutures to open the cuff and carefully sliding the vagus inside 
it. Electrical ground and heart electrodes were inserted into the 
surgical field. The impedances of the electrodes were tested to 
make sure they were less than 1 kOhm at 1 kHz. The surgical 
field was then rinsed with sterile saline and the skin 
temporarily closed using towel clamps.  
2.4.5. Electric stimulation. The optimised arrays were 
placed around the vagus nerve during terminal experiments in 
 
Figure 5. The experimental setup for in vivo evaluation. 
a) An optimal electrode array was manufactured and b) 
implanted on the vagus nerve of an anaesthetised sheep. 
Physiological parameters were measured whilst probing the 
circumferential electrode locations with 30 s stimulation 
followed by 30 s interstimulus time. The bottom figure 
shows the placement of the cuff electrode array on the 
vagus nerve. 
  
12 healthy sheep (Figure 5). A protocol of stimulation with the 
multi-electrode array was generated using MATLAB. 
Stimulation was delivered to the RVN using one pair of 
longitudinally paired electrodes at a time. Each stimulation 
consisted of a period of 30 s of stimulation and 30 s of 
recovery. Matched longitudinal pairs in the same radial 
position on both rings were sequentially selected for current 
application. All the stimulations were performed while the 
sheep was at steady state and the same depth of anaesthesia. 
Physiological endpoints were measured (EtCO2, ECG, ABP) 
from which HR and RR were calculated. During the 
experiment, current amplitude was adjusted in 100 μA steps 
so that: a) significant (more than 5%) physiological effects of 
stimulation for both RR reduction and HR reduction were 
present in at least one out of the 14 pairs, and b) the effects do 
not intersect, i.e. the stimulation of any ‘RR’-sensitive pair 
does not cause HR changes, and vice versa. The selected 
amplitude of stimulating current was recorded and used 
throughout for reproducibility. The observed responses for 
each stimulation pair were displayed, evaluated and compared 
with the baseline (30 sec prior to stimulation). Stimulation was 
delivered with a square biphasic (positive first) constant 
current temporal waveform using a balanced current source 
(Keithley, UK model no 6221, with a pulsewidth of 100 μs; 
50 μs for each phase and no interphase delay). The frequency 
of pulses was 20 Hz.  
3. Results 
3.1 Optimisation in simulations 
3.1.1. Optimisation step 1. The current density beneath the 
electrodes exponentially decreased with electrode area (Figure 
6.d). Despite this, however, the total injected current required 
for fibre activation did not change exponentially with 
electrode area (Figure 6.e). It was 35020 μA for the deep, and 
16010 μA for the superficial fibres with the smallest 
electrodes (0.05 mm2), compared to 42010 μA and 20010 
μA, respectively, for the largest (2 mm2). The influence of the 
geometry was apparent in the longitudinal shape of activating 
functions (Figure 6.c). This subsequently altered the threshold 
of activation, with the most influential parameter being the 
distance between the electrodes (Figure 7.a): for the shortest 
electrodes (0.5 mm) located close together (0.5 mm) it was 
9.90.1*107 mV/cm2 which was halved (51*107 mV/cm2) 
when the same electrodes were located 4.5 mm apart. Analysis 
of the OCF showed that the electrode length did not alter the 
function significantly, apart from the very short electrode case 
(Figure 7.b, P > 0.5), although the general trend was that the 
deeper fascicle was activated more efficiently with longer 
electrodes.  
The most significant parameter for optimisation was the 
electrode width (Figure 7.c), which changed the OCF value 
significantly (P < 0.01) across the range of configurations. 
 
Figure 6. a) Two examples of simulated bipolar symmetric 
electrode pairs. b) The potential (colour) and current 
density (red vectors) distribution within the simulated 
volumes of the nerve section. c) Activating functions for the 
above cases, taken along the deep (green) and superficial 
(blue) fibre locations. d) Threshold current density beneath 
the electrodes for activating deep (green) and superficial 
(blue) fibre VS total electrode area. e) Threshold current for 
activating deep (green) and superficial (blue) VS total 
electrode area. 
 
  
Electrodes wider than 0.8 mm produced a significant artificial 
drop in OCF (Figure 7.c): reduction in current density on the 
electrodes was no longer compensated by an increase of the 
affected area, as at this point it was equal to half of the nerve 
and could not increase further. These configurations were 
therefore discarded. 
The absolute minimum of the combined OCF was with 0.4 
mm width, 0.5 mm length, and 3 mm distance between the 
electrodes. However, after evaluating the manufacturing 
constraints (accuracy of the laser cut and overall stability of 
the device) and considering contact impedance value as an 
additional parameter (longer electrodes produced lower 
impedance, but did not significantly alter OCF (Figure 7.b), it 
was decided to select another configuration, which was in the 
top 1% but had much longer electrode length (Table 2). 
3.1.2. Optimisation step 2. The optimal bipolar longitudinal 
configuration evaluation was followed by the proof of the 
hypothesis that this configuration is optimal among any 
geometric electrode geometries. Since the problem is 
symmetric, one of the electrodes was fixed in its optimal state, 
whilst the second was changed with the simultaneous 
objective function calculation. The OCF was 5% higher for 
10% width variation, 1% higher for 10% length variation, and 
1% higher for 10% radial position variation. It was more than 
50% higher for any of the adjacent configurations, and more 
than 30% higher for two cases of multi-electrode 
configurations (see Figure 3 for illustration).  
3.1.3. Optimisation step 3. For the full multi-electrode array 
layout, the inter-electrode circumferential distance – or the 
distance between neighbouring pairs for the optimal geometry 
– was 0.35 mm. The electrode width was then slightly adjusted 
so that the complete circumference of the nerve was covered 
leading to 14 electrode pairs around the 2.8 mm-diameter 
nerve (Figure 5.a).  
Electrodes were successfully manufactured; contact 
impedance values in saline were 297  ±  1.04 Ω at 1 kHz (n = 
28 individual electrodes). 
 
Table 2. Optimal parameters of the simulated array, and 
actual manufactured device after consideration of production 
constrains 
Parameter Optimal 
design 
Manufactured 
near-optimal 
device 
Width 0.4 mm 0.35 mm 
Length 0.5 mm 3 mm 
Distance between the 
electrodes 
3 mm 3 mm 
Number of electrodes 14 14 
Percentile of OCF 
across all other 
combinations 
best 
(OCF = 
0.14) 
Top 1% (OCF 
= 0.16) 
 
Figure 7. Summary of simulation results with bipolar 
longitudinal electrode configuration. a) Threshold of 
activation variation with respect to distance between the 
electrodes for the shortest (0.5 mm) electrodes. b) OCF 
dependence on the length of the electrode for the deep 
(green) and the superficial (blue) fibres. c) OCF vs. 
electrode width for the deep (green), and the superficial 
(blue) fibres, and combined (red). 
  
3.2 In vivo evaluation 
Reproducible changes in both RR and HR in response to 
stimulation occurred in all 12 anaesthetised sheep (P < 0.01, 
Figure 8). Sequential stimulation with increasing current was 
applied until a clear bradypnea response was observed in at 
least one pair of electrodes. The stimulation current was then 
adjusted to maintain the significant response (reduction in RR) 
induced during stimulation through at least one electrode pair, 
while making sure RR and HR responses do not intersect, i.e. 
the RR-sensitive stimulation pair does not cause HR changes, 
and vice versa. This optimal current amplitude was 500  50 
μA (N = 24 in 12 sheep). In this condition, a separate area 
evoking a cardiac response (reduction in HR) to stimulation 
could be identified in 9 out of the 12 animals. In three out of 
the 12 sheep, the HR did not change significantly during 
stimulation through any of the pairs tested even after further 
increase in current amplitude which caused RR response in all 
14 pairs.  
Across all animals, the RR was reduced by 85  5% with 
no change in HR (P > 0.5) when stimulating through the pair 
of electrodes evoking an optimal bradypnea response in all 
sheep. The HR was reduced by 20  7% with no change in RR 
(P > 0.5) when stimulating through the pair of electrodes 
evoking optimal cardiac response (N = 24 in 12 sheep).  
The data from all animals was grouped together by 
rotational alignment by best respiratory-responsive site. The 
%RR and %HR change, with respect to the baseline, was 
calculated for each dataset, normalised across all animals, and 
plotted on the diagram. This revealed significant spatial 
localisation of respiratory- and cardiac- responsive sites with 
respect to each other (P < 0.01, Figure 9) with an angular 
position of 105  5 degrees.  
Discussion 
4.1 Summary of results. 
Optimisation of the electrode geometry in simulations 
allowed objective determination of geometrical parameters for 
selective neuromodulation of myelinated fibres in the vagus 
nerve. The best geometric configuration, given the biphasic 
square pulse application, was the symmetric longitudinal, 
same “o’clock” pair. The optimal electrode array had 14 
longitudinal electrode pairs, located 3 mm apart. The optimal 
width was 0.4 mm, with 0.35 mm inter-electrode 
circumferential distance, and a length of 0.5 mm. The latter 
was found to not significantly alter the objective function and 
was replaced by 3 mm (with minimal penalty) due to contact 
impedance and manufacturability considerations.  
Further analysis showed that using non-symmetric 
electrode geometries, as well as multi-electrode geometries, 
does not improve OCF when they are used with a bi-polar 
current source.  
The arrays were manufactured and tested in healthy 
anaesthetised animals, where the stimulation current was 
adjusted to ensure spatial selectivity of the stimulation. The 
resulting current amplitude of 500  50 μA for this array was 
not too far from that predicted by simulations, which was 
between 200 and 400 μA depending on the targeted fibre 
location. The detected mismatch is likely due to the thin layer 
of saline between the electrode and the nerve, which was not 
modelled. This might also explain the variance between 
animals (the range was between 200 and 800 μA) as the nerve 
thicknesses varied from animal to animal. This, however, 
should not significantly modify the optimisation results as the 
generic model scales the electric field distribution linearly 
and, although the total current is different, the OCF converges 
to a minimum at the same geometrical configuration. Results 
also demonstrate the potential of the generic model to be a 
good compromise when unknown a priori nerve geometry is 
under investigation. 
Overall, given the successful results of in vivo validation, 
the proposed generic model-based approach could be applied 
to optimise the geometry for cuffs of different diameters.  
For the first time, reliable and reproducible selectivity in 
neuromodulation of respiration-specific and cardiac-specific 
fibres was demonstrated and confirmed. These experimental 
results also strongly suggest spatial organisation of organ-
specific fibres in the cervical vagus nerve even in large 
animals.  
From a clinical perspective, all of the above also 
demonstrated that cardiac-specific and/or respiration-specific 
neuromodulation is possible without inadvertent stimulation 
of the other function. A potential application of this approach 
would be a refined vagus nerve stimulation method which 
targets specific areas of the nerve while avoiding the 
stimulation of unwanted response transmitted to other organs.  
In addition, even if the particular therapeutic effect of vagus 
nerve stimulation is difficult or impossible to quantify acutely, 
the specific cardio-respiratory nerve sections could be 
identified by trial-and-error and the current could be applied 
such that these effects are minimised (e.g. driving it through 
the pair which is at maximal distance from both).   
4.2 Study technical limitations and future work 
First, the study was limited to only consider a bi-polar 
current source and a bi-phasic symmetric current pulse. It was 
done on the basis of engineering practicality and reliability; 
however, authors admit that further investigations are 
required, and, in fact, a 2-electrode longitudinal configuration 
might not be the best in the case of a non-symmetric current 
pulse.  
Secondly, the study was only limited to myelinated fibres. 
This was done with the applicability to the existing trends in 
implantable stimulators and the particular diseases; however, 
non-myelinated fibres are currently under investigation.  
  
Thirdly, the study was limited to a generic nerve model not 
accounting for fascicular structure; however, previous studies 
[30] suggest that this does not affect the applicability of the 
model for optimisation purposes without a priori knowledge 
about the fascicular structure. 
Future work will be concentrated on the further 
optimisation of stimulation using multiple current sources, as 
well as fibre-specific and direction-specific stimulation 
paradigms, with the view of delivering the ultimate device for 
spatial, directional and fibre-selective therapeutic 
neuromodulation in complex nerves. 
Finally, the use of sheep as an animal model allowed using 
human-size vagus nerves as well as a model very often used 
for studying cardiac functions. However, in the sheep, the 
nerve may contain fibres innervating the rumen, which is 
obviously not human-related. It is therefore planned to 
validate the array in other large animal species such as pig. 
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Figure 8. Three examples of the experimental results at optimal current levels. The stimulus pulse was delivered to the 
longitudinal electrode pair at each of the 14 possible circumferential “o’clock” locations (indicated by the pictograms above) 
for 30 s, followed by a 30 s interstimulation interval. In all animals, there were pairs which induced significant alterations 
in breathing pattern (down to full apnoea, green squares), whilst others caused significant bradycardia (red square).  
 
Figure 9. Summary of results across all animals. Each dot represents the significant respiration- (blue dots) and cardiac- 
(red dots) specific “o’clock” site, and aligned by most respiration-specific. The radial position indicates the normalised % 
change from the baseline (maximum 100% for RR and 32% for HR, shown on the right, N = 24 in 12 sheep).   
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